What are the immunological consequences of long-term use of biological therapies for juvenile idiopathic arthritis?
出版年份 2013 全文链接
标题
What are the immunological consequences of long-term use of biological therapies for juvenile idiopathic arthritis?
作者
关键词
Attention Deficit Hyperactivity Disorder, Infliximab, Etanercept, Juvenile Idiopathic Arthritis, Adalimumab
出版物
ARTHRITIS RESEARCH & THERAPY
Volume 15, Issue 3, Pages 213
出版商
Springer Nature
发表日期
2013-06-04
DOI
10.1186/ar4213
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Brief Report: Incidence of Selected Opportunistic Infections Among Children With Juvenile Idiopathic Arthritis
- (2013) Timothy Beukelman et al. ARTHRITIS AND RHEUMATISM
- Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011
- (2012) D E Furst et al. ANNALS OF THE RHEUMATIC DISEASES
- Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease
- (2012) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment
- (2012) Timothy Beukelman et al. ARTHRITIS AND RHEUMATISM
- Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: Evolving role of biologic therapies
- (2012) Eamonn S. Molloy et al. ARTHRITIS AND RHEUMATISM
- Rates of malignancy associated with juvenile idiopathic arthritis and its treatment
- (2012) Timothy Beukelman et al. ARTHRITIS AND RHEUMATISM
- Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan
- (2012) Tomoyuki Imagawa et al. CLINICAL RHEUMATOLOGY
- The risk of contracting pediatric inflammatory bowel disease in children with celiac disease, epilepsy, juvenile arthritis and type 1 diabetes—a nationwide study
- (2012) Lauri J. Virta et al. Journal of Crohns & Colitis
- Incidence of acquired demyelinating syndromes of the CNS in Dutch children: a nationwide study
- (2012) I. A. Ketelslegers et al. JOURNAL OF NEUROLOGY
- Safety and response to influenza vaccine in patients with systemic-onset juvenile idiopathic arthritis receiving tocilizumab
- (2012) Toshihiko Shinoki et al. Modern Rheumatology
- Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Nicolino Ruperto et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Fabrizio De Benedetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term outcome of patients with JIA treated with etanercept, results of the biologic register JuMBO
- (2012) K. Minden et al. RHEUMATOLOGY
- A 5-year prospective population-based study of juvenile chronic arthritis: onset, disease process, and outcome
- (2012) L Bertilsson et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Effective seroconversion and safety following the pandemic influenza vaccination (anti-H1N1) in patients with juvenile idiopathic arthritis
- (2012) NE Aikawa et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Efficacy and safety of oral and parenteral methotrexate therapy in children with juvenile idiopathic arthritis: An observational study with patients from the German Methotrexate Registry
- (2012) A. Klein et al. ARTHRITIS CARE & RESEARCH
- 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
- (2012) Jasvinder A. Singh et al. ARTHRITIS CARE & RESEARCH
- Quantiferon-TB Gold in tube assay for the screening of tuberculosis before and during treatment with tumor necrosis factor alpha antagonists
- (2012) Gulen Hatemi et al. ARTHRITIS RESEARCH & THERAPY
- EULAR recommendations for vaccination in paediatric patients with rheumatic diseases
- (2011) M. W. Heijstek et al. ANNALS OF THE RHEUMATIC DISEASES
- Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial
- (2011) P. Tynjala et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab-Associated Progressive Multifocal Leukoencephalopathy in Rheumatoid Arthritis
- (2011) David B. Clifford ARCHIVES OF NEUROLOGY
- Performance of tuberculin skin test and interferon gamma assay for the diagnosis of latent tuberculosis infection in juvenile idiopathic arthritis
- (2011) Seçil Arslansoyu Çamlar et al. CLINICAL RHEUMATOLOGY
- Efficacy and safety of repeat courses of rituximab treatment in patients with severe refractory juvenile idiopathic arthritis
- (2011) Ekaterina I. Alexeeva et al. CLINICAL RHEUMATOLOGY
- Malignancies in Juvenile Idiopathic Arthritis: A Preliminary Report
- (2011) S. BERNATSKY et al. JOURNAL OF RHEUMATOLOGY
- Combination Therapy of Abatacept and Anakinra in Children with Refractory Systemic Juvenile Idiopathic Arthritis: A Retrospective Case Series
- (2011) J. L. RECORD et al. JOURNAL OF RHEUMATOLOGY
- Development of Inflammatory Bowel Disease in Patients with Juvenile Idiopathic Arthritis Treated with Etanercept
- (2011) T. D. van DIJKEN et al. JOURNAL OF RHEUMATOLOGY
- Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis
- (2011) Tomoyuki Imagawa et al. Modern Rheumatology
- Immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis
- (2011) Laura Dell’Era et al. VACCINE
- 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features
- (2011) Timothy Beukelman et al. ARTHRITIS CARE & RESEARCH
- Integrated safety in tocilizumab clinical trials
- (2011) Michael H Schiff et al. ARTHRITIS RESEARCH & THERAPY
- Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension
- (2010) N. Ruperto et al. ANNALS OF THE RHEUMATIC DISEASES
- A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
- (2010) P. Quartier et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk factors for development of uveitis differ between girls and boys with juvenile idiopathic arthritis
- (2010) R. K. Saurenmann et al. ARTHRITIS AND RHEUMATISM
- Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis
- (2010) Nicolino Ruperto et al. ARTHRITIS AND RHEUMATISM
- Juvenile idiopathic arthritis and risk of cancer: A nationwide cohort study
- (2010) J. F. Simard et al. ARTHRITIS AND RHEUMATISM
- Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: Report of forty-six patients from an international multicenter series
- (2010) Peter A. Nigrovic et al. ARTHRITIS AND RHEUMATISM
- The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritis
- (2010) Joost Frans Swart et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Primary immunodeficiencies may reveal potential infectious diseases associated with immune-targeting mAb treatments
- (2010) László Maródi et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Critical Role for TNF in the Induction of Human Antigen-Specific Regulatory T Cells by Tolerogenic Dendritic Cells
- (2010) F. S. Kleijwegt et al. JOURNAL OF IMMUNOLOGY
- Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials
- (2010) R. F. van VOLLENHOVEN et al. JOURNAL OF RHEUMATOLOGY
- The safety profile of biologic therapies for juvenile idiopathic arthritis
- (2010) Philip J. Hashkes et al. Nature Reviews Rheumatology
- Summary of worldwide pediatric malignancies reported after exposure to etanercept
- (2010) Peter McCroskery et al. Pediatric Rheumatology
- Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients
- (2010) T. R. Southwood et al. RHEUMATOLOGY
- Report on malignancies in the German juvenile idiopathic arthritis registry
- (2010) G. Horneff et al. RHEUMATOLOGY
- The effect of anti-TNF treatment on the immunogenicity and safety of the 7-valent conjugate pneumococcal vaccine in children with juvenile idiopathic arthritis
- (2010) Evangelia Farmaki et al. VACCINE
- The effect of immunomodulators on the immunogenicity of TNF-blocking therapeutic monoclonal antibodies: a review
- (2010) Charlotte Krieckaert et al. ARTHRITIS RESEARCH & THERAPY
- Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab
- (2009) Sander van Assen et al. ARTHRITIS AND RHEUMATISM
- Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor
- (2009) Zehra Kaymakcalan et al. CLINICAL IMMUNOLOGY
- Anakinra for Systemic Juvenile Arthritis
- (2009) Andrew Zeft et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Purified Protein Derivative Response in Juvenile Idiopathic Arthritis
- (2009) E. KIRAY et al. JOURNAL OF RHEUMATOLOGY
- Safety and efficacy of once weekly etanercept 0.8 mg/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis
- (2009) G. Horneff et al. RHEUMATOLOGY
- Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register
- (2008) F H M Prince et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry
- (2008) G Horneff et al. ANNALS OF THE RHEUMATIC DISEASES
- Mechanisms for cytotoxic effects of anti–tumor necrosis factor agents on transmembrane tumor necrosis factor α–expressing cells: Comparison among infliximab, etanercept, and adalimumab
- (2008) Hiroki Mitoma et al. ARTHRITIS AND RHEUMATISM
- Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis
- (2008) Daniel J. Lovell et al. ARTHRITIS AND RHEUMATISM
- Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study
- (2008) Norman Ilowite et al. CLINICAL RHEUMATOLOGY
- The significance of persistent newly developed autoantibodies in JIA patients under long-term anti-TNF treatment
- (2008) Florence Kanakoudi-Tsakalidou et al. CYTOKINE
- Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
- (2008) Shumpei Yokota et al. LANCET
- Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial
- (2008) Nicolino Ruperto et al. LANCET
- Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis
- (2008) Daniel J. Lovell et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started